Austrianova was founded in 2001. Austrianova's prime directive is to be a world leader in the research, development and application of new generations of targeted gene delivery systems. In addition the company aims to further develop programmes aimed at the treatment of breast and pancreatic cancer, as well as develop new generations of virus vector designed to more efficiently target and deliver therapeutic genes to diseased cells.
R&D
To view this information, you must subscribe to PL Intelligence.
Partnerships
To view this information, you must subscribe to PL Intelligence.
Deals
To view this information, you must subscribe to PL Intelligence.
Senior management
To view this information, you must subscribe to PL Intelligence.
Board of directors
To view this information, you must subscribe to PL Intelligence.
Contact details
To view this information, you must subscribe to PL Intelligence.
Head office
Austrianova
Veterinärplatz 1,
Vienna
A-1210 Austria
All rights reserved. Terms and Conditions | Contact us
